Group items tagged

The purpose of this Funding Opportunity Announcement is to solicit applications for the Vaccine and Treatment Evaluation Units (VTEUs) to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC). A companion FOA solicits applications for the Leadership Group for the Infectious Diseases Clinical Research Consortium, hereafter referred to as the Leadership Group (LG), which provides for overall administrative and scientific leadership for the clinical research and clinical trials conducted. While the primary scientific focus will be on product evaluation for NIAID priority areas, including malaria/neglected tropical diseases, sexually transmitted infections, respiratory infections, and enteric diseases, the VTEUs must also provide surge capacity to address emerging infectious diseases

For over forty years, the U.S. Centers for Disease Control and Prevention (CDC) has partnered with the Government of Kenya (GoK) to protect the health of the Kenyan people and strengthen health systems. The United States Government remains the largest investor in Kenya's health sector. This investment includes PEPFAR (President's Emergency Plan for AIDS Relief), GHSA (Global Health Security Agenda), Malaria, TB, Immunizations and Influenza. This Notice of Funding Opportunity (NOFO) seeks to build upon activities funded by CDC to support USG global health priorities in Kenya through implementation of programs and activities that focus on strengthening public health programs. After five years of implementing and strengthening global health security systems, the USG will continue to advance prevent, detect, and respond strategies to mitigate threats. This NOFO's main outcomes are to: Improve prevention of avoidable epidemics including naturally occurring outbreaks and intentional or accidental releases of dangerous pathogens Improve ability to rapidly detect threats early, including detecting, characterizing, and reporting emerging biological threats Respond rapidly and effectively to public health threats of international concern Strengthen implementation science programs and platforms to improve health outcomes